Bioorganic & Medicinal Chemistry
Design, synthesis, and biological evaluation of 2-arylamino-4-(piperidin-4-yloxy)pyrimidines as potent EGFR<sup>T790M/L858R</sup> inhibitors to treat non-small cell lung cancer
Publication date: Available online 17 October 2022Source: Bioorganic & Medicinal ChemistryAuthor(s): Liangliang Tian, Xing Li, Zhenying Lv, Yin Yang, Luhong Wang, Dawei Xu, Xiaodong Ma, Youjun Xu